Legato Capital Management LLC raised its position in BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 40.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 66,910 shares of the company's stock after purchasing an additional 19,120 shares during the quarter. Legato Capital Management LLC's holdings in BrightSpring Health Services were worth $1,139,000 at the end of the most recent quarter.
A number of other large investors have also modified their holdings of BTSG. R Squared Ltd acquired a new stake in shares of BrightSpring Health Services in the fourth quarter valued at about $74,000. Intech Investment Management LLC acquired a new stake in shares of BrightSpring Health Services in the third quarter valued at about $159,000. nVerses Capital LLC grew its stake in shares of BrightSpring Health Services by 195.8% in the third quarter. nVerses Capital LLC now owns 14,200 shares of the company's stock valued at $208,000 after buying an additional 9,400 shares in the last quarter. BNP Paribas Financial Markets grew its stake in shares of BrightSpring Health Services by 5.0% in the third quarter. BNP Paribas Financial Markets now owns 21,329 shares of the company's stock valued at $313,000 after buying an additional 1,011 shares in the last quarter. Finally, SG Americas Securities LLC acquired a new stake in shares of BrightSpring Health Services in the third quarter valued at about $360,000.
BrightSpring Health Services Stock Down 0.1 %
Shares of NASDAQ BTSG traded down $0.03 during trading hours on Friday, hitting $22.05. 617,340 shares of the company's stock were exchanged, compared to its average volume of 1,595,064. BrightSpring Health Services, Inc. has a 1-year low of $7.85 and a 1-year high of $24.82. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97. The company's 50-day moving average price is $19.55 and its 200-day moving average price is $16.72.
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on BTSG shares. Mizuho raised their price objective on BrightSpring Health Services from $17.00 to $20.00 and gave the company an "outperform" rating in a research note on Monday, November 4th. Morgan Stanley lifted their target price on BrightSpring Health Services from $19.00 to $20.00 and gave the stock an "overweight" rating in a research report on Tuesday, December 17th. CJS Securities assumed coverage on BrightSpring Health Services in a report on Thursday, December 12th. They issued an "outperform" rating and a $27.00 price target on the stock. UBS Group raised their price target on BrightSpring Health Services from $22.00 to $30.00 and gave the stock a "buy" rating in a report on Wednesday, January 29th. Finally, Wells Fargo & Company raised their price target on BrightSpring Health Services from $17.00 to $21.00 and gave the stock an "overweight" rating in a report on Wednesday, November 27th. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $19.42.
Check Out Our Latest Analysis on BTSG
About BrightSpring Health Services
(
Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Read More

Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.